Cardiovascular malformations and other cardiovascular abnormalities in neurofibromatosis 1
Angela E. Lin(Massachusetts General Hospital), Bruce R. Korf(University of Alabama at Birmingham), P. Wolkenstein(Université Paris-Est Créteil), M. Sigorini(University of Parma), Minna Pöyhönen(Väestöliitto), Jan M. Friedman(University of British Columbia Hospital), Patricia Birch(University of British Columbia), Romano Tenconi(University of Padua), Kim Uhas(Children's Medical Center), E Bonioli(Istituto Giannina Gaslini), R Virdis(University of Parma), Corrado Romano(University of Catania), Marcella Lawrence(Le Bonheur Children's Hospital), Enikö K. Pivnick(University of Tennessee Health Science Center), Michihito Niimura(Jikei University School of Medicine)
American Journal of Medical Genetics
January 1, 2000
Cited by 241
Related Papers
Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting
|European Journal of Endocrinology|2017|1.1k
Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation
|Genetics in Medicine|2021|766
De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes
|Nature Genetics|2012|752
Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy
|Nature Genetics|2007|702
A recurrent 15q13.3 microdeletion syndrome associated with mental retardation and seizures
|Nature Genetics|2008|591